1. Home
  2. ROIV vs BCE Comparison

ROIV vs BCE Comparison

Compare ROIV & BCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Roivant Sciences Ltd.

ROIV

Roivant Sciences Ltd.

HOLD

Current Price

$29.34

Market Cap

20.7B

Sector

Health Care

ML Signal

HOLD

Logo BCE Inc.

BCE

BCE Inc.

HOLD

Current Price

$24.40

Market Cap

24.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
ROIV
BCE
Founded
2014
1880
Country
United Kingdom
Canada
Employees
N/A
38683
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
20.7B
24.2B
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
ROIV
BCE
Price
$29.34
$24.40
Analyst Decision
Strong Buy
Hold
Analyst Count
9
2
Target Price
$28.94
$30.50
AVG Volume (30 Days)
4.4M
2.5M
Earning Date
05-28-2026
05-07-2026
Dividend Yield
N/A
5.50%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$29,053,000.00
N/A
Revenue This Year
N/A
$3.56
Revenue Next Year
$744.61
$1.70
P/E Ratio
N/A
$5.19
Revenue Growth
N/A
N/A
52 Week Low
$10.58
$21.10
52 Week High
$30.33
$26.52

Technical Indicators

Market Signals
Indicator
ROIV
BCE
Relative Strength Index (RSI) 59.02 52.25
Support Level $27.00 $23.05
Resistance Level $30.26 $24.47
Average True Range (ATR) 0.87 0.39
MACD 0.09 0.12
Stochastic Oscillator 85.95 73.28

Price Performance

Historical Comparison
ROIV
BCE

About ROIV Roivant Sciences Ltd.

Roivant Sciences Ltd is a commercial-stage biopharmaceutical company dedicated to improving the delivery of healthcare to patients. It also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business. Its drug candidate VTAMA (tapinarof) is a treatment of plaque psoriasis in adult patients and is in its commercial stage. The other drug candidates in their different stages of development are; Batoclimab, IMVT-1402, Brepocitinib, Namilumab, and others.

About BCE BCE Inc.

BCE provides wireless, broadband, television, and landline phone services in Canada. It is one of the Big Three national wireless carriers, with over 10 million customers constituting about 30% of the market. It is also the incumbent local exchange carrier—the legacy telephone provider—throughout much of the eastern half of Canada, including in the most populous Canadian provinces: Ontario and Quebec. BCE has a media segment that holds television, radio, and digital media assets. BCE licenses the Canadian rights to HBO Max and Starz.

Share on Social Networks: